.Merck defeats incomes assumptions, rears purchases expectation on sturdy need for top medicines like Keytruda CNBCMerck & Co. (MRK United States) Beats Earnings Estimates as Keytruda Purchases Surge BloombergMerck Sell: Pharma Giant Posts Strong Results, But Overview Drops Short Client's Organization DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck beats profit and purchases desires amid Keytruda asset, but gives combined full-year outlook MarketWatch.